Fertilane, FertilAI's AI-driven platform, has demonstrated its ability to enhance the fertility treatment process significantly, with a 30% increase in average cycle yield and an 8% rise in clinical pregnancy rates. The platform's algorithms are designed using insights from the analysis of tens of millions of data points from over 100,000 patients. Its effectiveness is supported by over 10 publications in peer-reviewed journals and presentations at leading fertility conferences, including Fertility and Sterility, Reproductive BioMedicine Online, ASRM, and ESHRE.

Fertilane enables reproductive endocrinologists at the clinics to tailor clinical treatments with greater precision and enhances patient outcomes. Moreover, it aids clinic management teams in boosting operational efficiency, for instance, by optimising operating room schedules based on predicted best treatment days.

The platform is complemented by a patient-centric mobile app designed to streamline and clarify communication between the clinic and patients. It offers automated, clear, concise, and personalised information, significantly enhancing the patient experience. Clinics that have integrated Fertilane with this patient app reported a 25% reduction in nurse workload and a 30% increase in cycle numbers without expanding staff, thereby accommodating more patients with existing resources.

Patients have also seen substantial benefits, experiencing a 30% reduction in the need for blood and ultrasound tests, which translates to savings in time, money, and inconvenience. Additionally, their waiting time for new instructions halved.

“Our mission is to guide physicians to make the best treatment decisions for individual patients,” said Rohi Hourvitz, FertilAI CEO. “In addition, the app improves communications among the physician, patient, and clinic team, ensuring patients are fully informed every step of the way.”

With the demand for fertility treatments on the rise and clinics struggling to meet this demand, FertilAI's technologies offer a solution that enables these 10 clinics to assist a greater number of prospective parents than before.

FertilAI adopts a comprehensive approach that fosters collaboration among patients, clinicians, and medical teams, aiming to elevate the standard of fertility care. This data-driven strategy not only aligns with but also strengthens existing care processes, facilitating improved staffing management, facility usage, and surgical scheduling, and better balancing workloads and workflows through insights centred on both clinics and patients.

“Every patient responds differently to treatment,” said Hourvitz. “However, after analysing treatment cycles and outcomes from over 100,000 patients, we were able to learn patterns even on the most uncommon of cases, enabling us to provide physicians with accurate predictions and recommendations during every step of the treatment process.”

FertilAI's decision-support tools are designed to minimise errors in medication timing and other areas, enhance compliance, and eliminate unnecessary testing. The platform is Cloud-based and adheres to the highest standards of privacy and security compliance, including HIPAA, GDPR, and is certified under ISO 27001 and 27799.